No Exception for AI Semiconductor Beneficiaries... 5% Drop in US Measurement Stocks in a Day

On July 7 in U.S. trading, shares of Bruker Corporation (BRKR), the U.S. life-sciences instruments company, closed on the Nasdaq at $58.25, down 5.04% from the previous day. Trading volume exceeded 1.77 million shares, while its market capitalization fell to about $8.9 billion (roughly 12 trillion KRW), erasing approximately $430 million (around 600 billion KRW) in value in a single session.

Amid a two-week correction in global semiconductor and equipment stocks, Bruker has also been hit by profit-taking across the AI semiconductor supply chain. Nevertheless, Leerink Partners raised its price target for Bruker to $70, citing expectations that orders for semiconductor metrology equipment will grow by over 20% in 2025–2026.

In its first-quarter 2026 earnings reported in May, the company posted revenue of $823.4 million and adjusted EPS of $0.31, and reaffirmed its full-year 2026 guidance of $3.57–3.60 billion in revenue and $2.10–2.15 in adjusted EPS, thereby defending its outlook.

Bruker supplies high-performance scientific instruments—including NMR systems, mass spectrometers, and microscopes—along with microbial and molecular diagnostic solutions, holding a strong position in proteomics, multi-omics, microbial identification, and infectious disease diagnostics. While its superconducting magnets for MRI and next-generation semiconductor metrology tools make it a beneficiary of increased AI infrastructure and medical imaging investments, the stock exhibits significant performance and valuation volatility due to macro variables such as weakening demand in U.S. academia, tariffs, and exchange rates.